Dermira Reports First Quarter 2019 Financial Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Dermira (DERM) Tops Q1 EPS by 13c
May 7, 2019 4:37 PM EDTDermira (NASDAQ: DERM) reported Q1 EPS of ($1.49), $0.13 better than the analyst estimate of ($1.62). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $2.64 million.
Positive momentum continued into the first quarter 2019 at Dermira. Bolstered by significant prescription growth of QBREXZA... More
